NEUROENDOCRINE NEOPLASM
Clinical trials for NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapon tested against rare, Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage clinical trial is testing a new drug called CRN09682 for people with advanced neuroendocrine tumors and other solid tumors that have a specific marker (SST2). The main goals are to find a safe and tolerable dose and to see if the drug shows early signs of helping…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Massive study aims to unlock future cures by tracking 75,000 young cancer patients
Knowledge-focused Recruiting nowThis study is creating a large registry and tissue bank for children and young adults with cancer. It collects health information and leftover tissue samples from patients up to age 25 to help researchers understand these diseases better. The goal is to use this information to im…
Matched conditions: NEUROENDOCRINE NEOPLASM
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC